Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL
Condition(s):Chronic Lymphocytic Leukemia; Small Lymphocytic LymphomaLast Updated:September 19, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Chronic Lymphocytic Leukemia; Small Lymphocytic LymphomaLast Updated:September 19, 2019Terminated
Condition(s):Systemic Sclerosis; Pulmonary; HypertensionLast Updated:March 17, 2022Terminated
Condition(s):Multiple Sclerosis, Dimethyl Fumarate, Diffusion Tensor Imaging Magnetic Resonance ImagingLast Updated:October 26, 2016Completed
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:August 1, 2023Completed
Condition(s):Tecfidera; TeriflunomideLast Updated:January 6, 2021Completed
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:April 27, 2017Completed
Condition(s):Primary Progressive Multiple SclerosisLast Updated:December 24, 2020Completed
Condition(s):Intracerebral HemorrhageLast Updated:October 25, 2023Withdrawn
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:January 9, 2019Terminated
Condition(s):Multiple Sclerosis, Relapsing-Remitting; Relapsing-Remitting Multiple SclerosisLast Updated:April 8, 2016Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.